#78 – New Therapies in HIV: The Long Road to Long-acting Antiretrovirals - Are We There Yet?
Breakpoints
00:00
The Future of HIV Therapy
I think the big thing to keep in mind with some of these other therapies is that they're not intended to be used by themselves like we kind of talked about at the beginning. The way that lena capaver was studied was in conjunction with an optimized oral backbone therapy and I thought it was really nice the patients they focused on were the ones that only have two or less active antiretroviral agents available to them. That's going to be a huge paradigm shift for HIV therapy in general but one thing that I would like to see kind of moving forward is a lot of these are all things that have to be clinic administered.
Transcript
Play full episode
